Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J.

JAMA. 1999 Jul 14;282(2):137-44.

PMID:
10411194
[PubMed - indexed for MEDLINE]
2.

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.

Carter NJ, Curran MP.

Drugs. 2011 Aug 20;71(12):1591-622. doi: 10.2165/11206860-000000000-00000. Review.

PMID:
21861544
[PubMed - indexed for MEDLINE]
4.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

PMID:
16140685
[PubMed - indexed for MEDLINE]
Free PMC Article
5.
6.

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.

Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.

Ann Intern Med. 1992 Oct 15;117(8):625-33.

PMID:
1530193
[PubMed - indexed for MEDLINE]
7.

Live attenuated influenza virus vaccines: new options for the prevention of influenza.

Nichol KL.

Vaccine. 2001 Aug 14;19(31):4373-7. Review.

PMID:
11483261
[PubMed - indexed for MEDLINE]
8.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K.

JAMA. 2000 Oct 4;284(13):1655-63.

PMID:
11015795
[PubMed - indexed for MEDLINE]
11.

The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults.

Ambrose CS, Wu X.

Vaccine. 2013 Jan 30;31(6):857-60. doi: 10.1016/j.vaccine.2012.12.028. Epub 2012 Dec 20.

PMID:
23261050
[PubMed - indexed for MEDLINE]
Free Article
12.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.

N Engl J Med. 1998 May 14;338(20):1405-12.

PMID:
9580647
[PubMed - indexed for MEDLINE]
Free Article
13.

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.

Vaccine. 2011 Nov 21;29(50):9391-7. doi: 10.1016/j.vaccine.2011.09.109. Epub 2011 Oct 6.

PMID:
21983154
[PubMed - indexed for MEDLINE]
14.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
[PubMed - indexed for MEDLINE]
15.

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.

PMID:
11740317
[PubMed - indexed for MEDLINE]
16.

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.

Mallory RM, Yi T, Ambrose CS.

Vaccine. 2011 Jun 10;29(26):4322-7. doi: 10.1016/j.vaccine.2011.04.022. Epub 2011 Apr 20.

PMID:
21513761
[PubMed - indexed for MEDLINE]
17.

Effectiveness of influenza vaccine in health care professionals: a randomized trial.

Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC.

JAMA. 1999 Mar 10;281(10):908-13.

PMID:
10078487
[PubMed - indexed for MEDLINE]
18.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
[PubMed - indexed for MEDLINE]
19.

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.

Wang Z, Tobler S, Roayaei J, Eick A.

JAMA. 2009 Mar 4;301(9):945-53. doi: 10.1001/jama.2009.265. Epub 2009 Mar 2.

PMID:
19255113
[PubMed - indexed for MEDLINE]
20.

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

Halloran ME, Piedra PA, Longini IM Jr, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.

Vaccine. 2007 May 16;25(20):4038-45. Epub 2007 Mar 12.

PMID:
17395338
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk